• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of the elective introduction of extracorporeal membrane oxygenation on outcomes in pediatric myocarditis cases.选择性引入体外膜肺氧合对小儿心肌炎病例预后的影响。
Acute Med Surg. 2014 Sep 17;2(2):92-97. doi: 10.1002/ams2.76. eCollection 2015 Apr.
2
Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediatric patients with refractory cardiac arrest.小儿难治性心脏骤停患者实施挽救性体外心肺复苏后的生存结局
J Thorac Cardiovasc Surg. 2007 Oct;134(4):952-959.e2. doi: 10.1016/j.jtcvs.2007.05.054.
3
Extracorporeal membrane oxygenation for the support of pediatric patients with acute fulminant myocarditis.体外膜肺氧合用于支持急性暴发性心肌炎的儿科患者。
Turk J Pediatr. 2019;61(6):867-872. doi: 10.24953/turkjped.2019.06.007.
4
Elective decompression of the left ventricle in pediatric patients may reduce the duration of venoarterial extracorporeal membrane oxygenation.对儿科患者进行选择性左心室减压可能会缩短静脉动脉体外膜肺氧合的持续时间。
Artif Organs. 2015 Apr;39(4):319-26. doi: 10.1111/aor.12390. Epub 2014 Oct 20.
5
[Clinical features and outcomes of pediatric acute fulminant myocarditis requiring extracorporeal membrane oxygenation].[需要体外膜肺氧合的小儿急性暴发性心肌炎的临床特征及预后]
Zhonghua Yi Xue Za Zhi. 2019 Dec 17;99(47):3715-3719. doi: 10.3760/cma.j.issn.0376-2491.2019.47.008.
6
Extracorporeal membrane oxygenation for the support of adults with acute myocarditis.体外膜肺氧合支持成人急性心肌炎。
Crit Care Med. 2015 May;43(5):1016-25. doi: 10.1097/CCM.0000000000000920.
7
Functional Status Change Among Children With Extracorporeal Membrane Oxygenation to Support Cardiopulmonary Resuscitation in a Pediatric Cardiac ICU: A Single Institution Report.体外膜肺氧合支持心肺复苏后儿科心脏重症监护病房患儿的功能状态变化:单中心报告。
Pediatr Crit Care Med. 2018 Jul;19(7):665-671. doi: 10.1097/PCC.0000000000001555.
8
Clinical presentation of pediatric myocarditis in Taiwan.台湾地区小儿心肌炎的临床表现。
Pediatr Neonatol. 2011 Jun;52(3):135-9. doi: 10.1016/j.pedneo.2011.03.005. Epub 2011 May 31.
9
Delayed extracorporeal membrane oxygenation in children after cardiac surgery: two-institution experience.心脏手术后儿童延迟体外膜肺氧合:两家机构的经验
Cardiol Young. 2015 Feb;25(2):248-54. doi: 10.1017/S1047951113002011. Epub 2013 Dec 17.
10
Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Decision for Pediatric Fulminant Myocarditis.外周静脉-动脉体外膜肺氧合作为小儿暴发性心肌炎决策的桥梁
Artif Organs. 2016 Aug;40(8):793-8. doi: 10.1111/aor.12673. Epub 2016 Jan 27.

引用本文的文献

1
The use of extracorporeal membrane oxygenation in children with acute fulminant myocarditis.体外膜肺氧合在儿童急性暴发性心肌炎中的应用。
Clin Exp Pediatr. 2021 May;64(5):188-195. doi: 10.3345/cep.2020.00836. Epub 2020 Aug 10.
2
Long-stay pediatric patients in Japanese intensive care units: their significant presence and a newly developed, simple predictive score.日本重症监护病房中的长期住院儿科患者:他们的显著存在及一种新开发的简易预测评分
J Intensive Care. 2019 Jul 29;7:38. doi: 10.1186/s40560-019-0392-2. eCollection 2019.
3
Clinical Effect of Intravenous Vitamin C on Viral Myocarditis in Children: A Systematic Review and Meta-Analysis.静脉注射维生素C对儿童病毒性心肌炎的临床疗效:系统评价与Meta分析
Evid Based Complement Alternat Med. 2019 Apr 23;2019:3082437. doi: 10.1155/2019/3082437. eCollection 2019.
4
Neurologic Outcomes in a Two-Center Cohort of Neonatal and Pediatric Patients Supported on Extracorporeal Membrane Oxygenation.体外膜肺氧合支持的新生儿和儿科患者的神经结局:两中心队列研究。
ASAIO J. 2020 Jan;66(1):79-88. doi: 10.1097/MAT.0000000000000933.
5
Neurologic Outcomes After Extracorporeal Membrane Oxygenation: A Systematic Review.体外膜肺氧合治疗后的神经系统转归:一项系统综述。
Pediatr Crit Care Med. 2018 Aug;19(8):760-766. doi: 10.1097/PCC.0000000000001612.

本文引用的文献

1
Clinical characteristics and long-term outcome of acute myocarditis in children.儿童急性心肌炎的临床特征及长期预后
Heart Vessels. 2013 Sep;28(5):632-8. doi: 10.1007/s00380-012-0296-8. Epub 2012 Oct 13.
2
Comparison of the clinical presentation, treatment, and outcome of fulminant and acute myocarditis in children.比较儿童暴发性和急性心肌炎的临床表现、治疗和结局。
Circ J. 2012;76(5):1222-8. doi: 10.1253/circj.cj-11-1032. Epub 2012 Feb 4.
3
Clinical presentation of pediatric myocarditis in Taiwan.台湾地区小儿心肌炎的临床表现。
Pediatr Neonatol. 2011 Jun;52(3):135-9. doi: 10.1016/j.pedneo.2011.03.005. Epub 2011 May 31.
4
Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis.机械循环支持在儿童暴发性和持续性心肌炎中的疗效。
J Card Fail. 2011 Jun;17(6):487-94. doi: 10.1016/j.cardfail.2011.02.008. Epub 2011 Apr 22.
5
Short-term outcomes of acute fulminant myocarditis in children.儿童急性暴发性心肌炎的短期预后
Pediatr Cardiol. 2011 Oct;32(7):885-90. doi: 10.1007/s00246-011-0007-8. Epub 2011 May 17.
6
Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version.心肌炎诊断与治疗指南(2009年日本循环学会版):摘要版
Circ J. 2011;75(3):734-43. doi: 10.1253/circj.cj-88-0008. Epub 2011 Feb 4.
7
Management and outcomes in pediatric patients presenting with acute fulminant myocarditis.儿科暴发性心肌炎患者的管理和结局。
J Pediatr. 2011 Apr;158(4):638-643.e1. doi: 10.1016/j.jpeds.2010.10.015. Epub 2010 Dec 30.
8
Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry.体外膜肺氧合支持婴幼儿和青少年暴发性心肌炎患者:体外生命支持组织登记的回顾。
Crit Care Med. 2010 Feb;38(2):382-7. doi: 10.1097/CCM.0b013e3181bc8293.
9
Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation.小儿心肌炎:急诊科临床发现与诊断评估
Pediatrics. 2007 Dec;120(6):1278-85. doi: 10.1542/peds.2007-1073.
10
Myocarditis presenting as gastritis in children.小儿以胃炎形式表现的心肌炎。
Pediatr Emerg Care. 2006 Jun;22(6):439-40. doi: 10.1097/01.pec.0000221346.64991.e7.

选择性引入体外膜肺氧合对小儿心肌炎病例预后的影响。

Effects of the elective introduction of extracorporeal membrane oxygenation on outcomes in pediatric myocarditis cases.

作者信息

Nosaka Nobuyuki, Muguruma Takashi, Fujiwara Takeo, Enomoto Yuki, Toida Chiaki, Morishima Tsuneo

机构信息

Division of Acute and Critical Care Department of Critical Care and Anesthesia National Medical Center for Children and Mothers Tokyo Japan.

Department of Pediatrics Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan.

出版信息

Acute Med Surg. 2014 Sep 17;2(2):92-97. doi: 10.1002/ams2.76. eCollection 2015 Apr.

DOI:10.1002/ams2.76
PMID:29123700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5667200/
Abstract

AIM

To investigate the necessary indicators to diagnose pediatric myocarditis and choose appropriate candidates for extracorporeal membrane oxygenation therapy.

METHODS

We retrospectively reviewed the medical records of children aged <16 years of age who were diagnosed with myocarditis and admitted to the pediatric intensive care unit in a Japanese children's hospital from 2002 to 2013. We collected demographic data and symptoms and signs during the entire clinical course, investigated the survival and neurological outcomes, and identified the predictors of death.

RESULTS

Twenty-nine patients (median age, 5 years) met the inclusion criteria. Fever and gastrointestinal symptoms occurred in approximately 80% of the patients as initial symptoms and central nervous system symptoms were the most frequent symptom on emergency presentation (41%). Extracorporeal membrane oxygenation was administered to 16 patients; of these, five died. Of the 24 surviving patients, 23 achieved favorable neurological outcomes. Four of eight patients died following cardiopulmonary resuscitation-triggered extracorporeal membrane oxygenation, and one of eight died following elective extracorporeal membrane oxygenation. Multivariate analysis using stepwise logistic regression analysis revealed creatinine level as an independent predictor of death.

CONCLUSION

It is important to consider myocarditis when evaluating children with gastrointestinal or central nervous system symptoms. The elective introduction of extracorporeal membrane oxygenation before the completion of end-organ dysfunction has a positive effect on outcomes in pediatric myocarditis cases. Transfer to an institution that can initiate extracorporeal membrane oxygenation support should be promptly considered when managing pediatric myocarditis.

摘要

目的

研究诊断小儿心肌炎的必要指标,并为体外膜肺氧合治疗选择合适的患者。

方法

我们回顾性分析了2002年至2013年期间在日本一家儿童医院被诊断为心肌炎并入住儿科重症监护病房的16岁以下儿童的病历。我们收集了整个临床过程中的人口统计学数据、症状和体征,调查了生存情况和神经学结局,并确定了死亡的预测因素。

结果

29例患者(中位年龄5岁)符合纳入标准。约80%的患者最初症状为发热和胃肠道症状,中枢神经系统症状是急诊时最常见的症状(41%)。16例患者接受了体外膜肺氧合治疗;其中5例死亡。在24例存活患者中,23例获得了良好的神经学结局。8例心肺复苏后启动体外膜肺氧合治疗的患者中有4例死亡,8例择期体外膜肺氧合治疗的患者中有1例死亡。采用逐步逻辑回归分析的多变量分析显示肌酐水平是死亡的独立预测因素。

结论

在评估有胃肠道或中枢神经系统症状的儿童时,考虑心肌炎很重要。在终末器官功能障碍出现之前择期引入体外膜肺氧合对小儿心肌炎病例的结局有积极影响。在处理小儿心肌炎时,应及时考虑转至能够启动体外膜肺氧合支持的机构。